These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3982631)

  • 1. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups.
    Mayeux R; Stern Y; Spanton S
    Neurology; 1985 Apr; 35(4):453-61. PubMed ID: 3982631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical heterogeneity of Alzheimer's disease. Different clinical profiles can predict the progression rate].
    Mangone CA
    Rev Neurol; 2004 Apr 1-15; 38(7):675-81. PubMed ID: 15098191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical subtypes of dementia of the Alzheimer type.
    Chui HC; Teng EL; Henderson VW; Moy AC
    Neurology; 1985 Nov; 35(11):1544-50. PubMed ID: 4058744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and senile dementia of Alzheimer type. A neuropsychological study.
    Sulkava R; Amberla K
    Acta Neurol Scand; 1982 Jun; 65(6):651-60. PubMed ID: 7113669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive features in mild senile dementia of the Alzheimer type.
    Berg L; Danziger WL; Storandt M; Coben LA; Gado M; Hughes CP; Knesevich JW; Botwinick J
    Neurology; 1984 May; 34(5):563-9. PubMed ID: 6538648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia of frontal lobe type.
    Orrell MW; Sahakian BJ
    Psychol Med; 1991 Aug; 21(3):553-6. PubMed ID: 1946843
    [No Abstract]   [Full Text] [Related]  

  • 7. Dementia with parietal signs.
    McDonald C
    Br J Psychiatry; 1991 Jun; 158():859-60. PubMed ID: 1873640
    [No Abstract]   [Full Text] [Related]  

  • 8. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
    Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
    Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment: focus on diagnosis.
    de Mendonça A; Guerreiro M; Ribeiro F; Mendes T; Garcia C
    J Mol Neurosci; 2004; 23(1-2):143-8. PubMed ID: 15126699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis.
    Krinsky-McHale SJ; Silverman W
    Dev Disabil Res Rev; 2013; 18(1):31-42. PubMed ID: 23949827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease.
    Stern Y; Liu X; Albert M; Brandt J; Jacobs DM; Del Castillo-Castaneda C; Marder K; Bell K; Sano M; Bylsma F
    Arch Neurol; 1996 Nov; 53(11):1121-6. PubMed ID: 8912485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Global Deterioration Scale (GDS) and Functional Assessment Staging (FAST) in the diagnosis of Alzheimer type dementia].
    Krzymińska E; Rossa G; Krzymiński S
    Psychiatr Pol; 1993; 27(2):129-38. PubMed ID: 8378466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pisa syndrome without neuroleptic exposure in a patient with dementia of the Alzheimer type.
    Patel S; Tariot PN; Hamill RW
    J Geriatr Psychiatry Neurol; 1991; 4(1):48-51. PubMed ID: 2054053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population.
    Berg L; Hughes CP; Coben LA; Danziger WL; Martin RL; Knesevich J
    J Neurol Neurosurg Psychiatry; 1982 Nov; 45(11):962-8. PubMed ID: 7175540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric evaluation in dementia.
    Marshall GA; Cummings JL
    Handb Clin Neurol; 2008; 89():53-61. PubMed ID: 18631730
    [No Abstract]   [Full Text] [Related]  

  • 16. [Heterogeneity of Alzheimer's disease].
    Scheltens P; Vermersch P; Leys D
    Rev Neurol (Paris); 1993; 149(1):14-25. PubMed ID: 8337557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is it? Case 1, 1994: rapidly progressive aphasia, apraxia, dementia, myoclonus, and parkinsonism.
    Wojcieszek J; Lang AE; Jankovic J; Greene P; Deck J
    Mov Disord; 1994 May; 9(3):358-66. PubMed ID: 7518892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alzheimer-type dementia: clinical experience in 71 cases].
    Donoso A; Quiroz M; Yulis J
    Rev Med Chil; 1990 Feb; 118(2):139-45. PubMed ID: 2152712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it really Alzheimer's?
    Spooner MA
    Can Fam Physician; 1994 Jun; 40():1141-5. PubMed ID: 8019191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.